Results
SMS Pharma Q2 Revenue Up 30% YoY, Raises FY27 Guidance
SMS Pharmaceuticals reported Q2 FY27 revenue growth of 30% YoY to INR316 crore and raised its full-year guidance, now expecting to exceed initial targets.
The company highlighted strong performance dr
